Zoono Group Limited (AU:ZNO) has released an update.
Zoono Group Limited reports a positive quarterly update with a NZ$601K increase in cash receipts and a significant NZ$1.1M reduction in net cash operating costs. The company has generated strong interest in its shelf-life extension technology, leading to 21 trials with global companies across various industries. Optimism is high for potential future revenues, as Zoono also progresses in target Asian markets and expects ongoing business in sectors such as pharmaceuticals and farming.
For further insights into AU:ZNO stock, check out TipRanks’ Stock Analysis page.